CN106854682A - A kind of method that parting is carried out using gene infected by influenza - Google Patents

A kind of method that parting is carried out using gene infected by influenza Download PDF

Info

Publication number
CN106854682A
CN106854682A CN201611226906.0A CN201611226906A CN106854682A CN 106854682 A CN106854682 A CN 106854682A CN 201611226906 A CN201611226906 A CN 201611226906A CN 106854682 A CN106854682 A CN 106854682A
Authority
CN
China
Prior art keywords
influenza
parting
carried out
seq
viral rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611226906.0A
Other languages
Chinese (zh)
Inventor
陈升
丁方美
孙子奎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANGHAI PERSONAL BIOTECHNOLOGY CO Ltd
Original Assignee
SHANGHAI PERSONAL BIOTECHNOLOGY CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI PERSONAL BIOTECHNOLOGY CO Ltd filed Critical SHANGHAI PERSONAL BIOTECHNOLOGY CO Ltd
Priority to CN201611226906.0A priority Critical patent/CN106854682A/en
Publication of CN106854682A publication Critical patent/CN106854682A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A kind of method that parting is carried out using gene infected by influenza disclosed by the invention, is comprised the following steps:Step S1, viral RNA are extracted;Step S2, by viral RNA reverse transcription be cDNA;Step S3, entered using specific primer performing PCR amplification;Step S4, recovery pcr amplification product;Step S5, the recovery product is sequenced;Step S6, known array in sequencing result and public database is compared, unknown virus are divided to corresponding classification.The nucleotide sequence of the specific primer such as SEQ ID NO:1 to SEQ ID NO:Shown in 8.The method of the present invention is compared with traditional method based on Serologic detection, and the nucleic acid detection method detection efficiency of PCR-based principle is higher, more rapid and convenient, will be played a great role in the infectious disease emergency that happens suddenly.

Description

A kind of method that parting is carried out using gene infected by influenza
Technical field
The invention belongs to biology field, more particularly, to a kind of side that parting is carried out using gene infected by influenza Method.
Background technology
Influenza (influenza) is the Acute respiratory infectious disease caused by influenza virus, and infectiousness is stronger, clinically Based on the symptom such as hyperpyrexia, weak, headache, Muscular stiffness, often periodically trigger worldwide popular or be very popular.Stream Influenza Virus have three types:A type (A types) influenza infection mammal and birds;B-mode (Type B) influenza virus is only felt The dye mankind, the generation of disease is generally gentle compared with Alphavirus;Third type (c-type) influenza virus only infects the mankind, can't cause tight The disease of weight.From the point of view of infection scale, Flu-A often causes eruption and prevalence, even pandemics, occurs within about 2~3 years Small popular 1 time, according to the 4 pandemicities analysis for having occurred in the world, generation in general 10~15 years is once very popular.It is B-mode , in outburst or small prevalence, the third type is based on distributing for influenza.
The clinical symptoms of influenza are similar to common cold, but flu episode is rapid, and infectiousness is strong, and virus itself is to existing The drug resistance of medicine constantly strengthens, and vaccine protective effect is limited, therefore the quick of pathogen makes a definite diagnosis prevention of disease and early stage The influenza diagnostic criteria for treating the Ministry of Public Health's promulgation that is significant points out that antidiastole relies primarily on aetology, spy Heteronuclear acid is checked and serum antibody is determined.But rely on the classics sides such as virus purification culture, serodiagnosis and antigen detection Method wastes time and energy, it is difficult to adapt to during Epidemic outbreak of disease the need for quick diagnosis.And PCR detection method has, and sensitivity is high, specificity Good the advantages of, it is widely used in pathogen detection, is one of effective ways of pathogen antidiastole generally acknowledged at present.Accurate mirror Other influenza virus type, for monitoring influenza activity and fashion trend, and early warning is made in the variation of infected by influenza, for influenza Prevention and control be significant, while there is certain directive significance in diagnosis and treatment process to clinical line doctor.
The content of the invention
The technical problems to be solved by the invention are to be carried for the existing above-mentioned deficiency of existing influenza virus detection For a kind of method that parting is carried out using gene infected by influenza, the method can be sequenced to A type and B-mode by PCR and a generation Influenza virus carries out Genotyping.
The technical problems to be solved by the invention can be solved by the following technical programs:
A kind of method that parting is carried out using gene infected by influenza, is comprised the following steps:
Step S1, viral RNA are extracted;
Step S2, by viral RNA reverse transcription be cDNA;
Step S3, entered using specific primer performing PCR amplification;
Step S4, recovery pcr amplification product;
Step S5, the recovery product is sequenced;
Step S6, known array in sequencing result and public database is compared, unknown virus are divided to correspondence Classification.
In a preferred embodiment of the invention, the nucleotide sequence of the specific primer such as SEQ ID NO:1 to SEQ ID NO:Shown in 8.
The method of the present invention is compared with traditional method based on Serologic detection, the detection of nucleic acids side of PCR-based principle Method detection efficiency is higher, more rapid and convenient, will be played a great role in the infectious disease emergency that happens suddenly.
Brief description of the drawings
Fig. 1 is template-PCB products dosage schematic diagram of the present invention.
Fig. 2 is template of the present invention-copy number schematic diagram.
Fig. 3 and Fig. 4 is inventive samples type schematic diagram.
Specific embodiment
The present invention is described in further detail with reference to specific embodiments and the drawings.
1st, viral RNA is extracted
1.1st, virus stock solution used 500ul is added in the eppendorf pipes of 1.5ml, TRIzol 1ml are added, it is fully mixed Even, room temperature places 10min, it is ensured that virus coat is fully cracked;
1.2nd, the chloroform of 200ul is added, centrifugation lid is covered tightly, (solution is fully emulsified, into milky white firmly to shake centrifuge tube Shape, no phase separation phenomenon), room temperature places 10min, and (due to chloroform low boiling point, volatile, centrifuge tube may pop during vibration, small The heart);
1.3rd, 12000g room temperatures centrifugation 15min, takes upper phase and moves into another pipe (never inhaling dynamic white interphase);
1.4th, 500ul isopropanols are added, centrifuge tube is gently overturned and is fully mixed liquid, room temperature places 10min;
1.5th, 4 DEG C, 10000g centrifugation 10min, centrifugation finishes visible ttom of pipe white precipitate, and as RNA is carefully sucked with rifle All supernatants;
1.6th, the ethanol of 1ml 75% is added, allows RNA precipitate to hang, 4 DEG C, 7500g centrifugation 5min carefully suck institute with rifle There is supernatant, 5min is dried in super-clean bench;
1.7th, appropriate DEPC treatment water is added.
1.8th, RT is in suggestion immediately.To preserve, can be frozen in -70 DEG C after previous step adds ethanol, one can be preserved Year;Can only be preserved 1 month or so at -20 DEG C if adding after DEPC water.
2nd, it is cDNA by viral RNA reverse transcription
2.1 add following reactant mixture in the test tube of ice bath:
Template ribonucleic acid:Total serum IgE 1-3 μ g
Primer:Oligo(dT)(50uM) 1μl
dNTP Mix(10mmol/L) 1μl
The 2.2 plus μ l of RNase free dH2O to 10,65 DEG C of incubation 5min after mixing, rapid ice bath after terminating.
2.3 add following reactant mixture in the test tube of ice bath:
Plus after the μ of RNase free dH2O to 20 l are gently mixed.
2.4 42 DEG C of reactant mixture 30-60min.
2.5 heat 5min at 95 DEG C terminates reaction, and put carries out subsequent experimental or freezen protective on ice.
3rd, design of primers
This patent in order to improve detection efficiency, stromatin (M) gene and hemagglutinin (HA) gene according to influenza virus And neuraminidase (NA) separately designs primer and expanded, these primers are closed by upper Shanghai's style Sen Nuo bio tech ltd Into primer sequence is as follows:
4.PCR is expanded:Enter performing PCR amplification to viral cDNA, obtain genetic fragment to be measured
Amplification system and program are as follows:
Following component is added in 0.2ml centrifuge tubes:
Mixing is flicked, the drop on brief centrifugation collection tube wall to ttom of pipe, in the enterprising performing PCR reaction of PCR amplification instrument, reaction Parameter is as follows:
After the completion of reaction, taking 3ulPCR products carries out 1% agarose gel electrophoresis detection.Confirm pcr amplified fragment.
5th, the recovery of PCR primer
PCR primer is reclaimed with AxyPrep DNA gels QIAquick Gel Extraction Kit, and concrete operations are carried out by kit specification, is walked It is rapid as follows:
5.1 cut the Ago-Gel containing target DNA under uviol lamp is put into clean centrifuge tube, weighs weight.
5.2 add 3 Buffer DE-A of gel volume, are well mixed after 75 DEG C of heating until gel piece melts completely Change.
5.3 plus 0.5 Buffer DE-B of Buffer DE-A volumes, is well mixed;When separate DNA fragmentation is less than During 400bp, 1 isopropanol of gel volume is added.
5.4 by mixed liquor, is transferred to DNA and prepares pipe 12,000 × g centrifugations 1min.Abandon filtrate.
5.5 will prepare pipe puts back into 2ml centrifuge tubes, plus 500 μ l Buffer W1,12,000 × g centrifugation 30s, abandons filtrate.
5.6 will prepare pipe puts back into 2ml centrifuge tubes, plus 700 μ l Buffer W2,12,000 × g centrifugation 30s, abandons filtrate.With Same method is again with 700 μ l Buffer W2,12,000 × g centrifugations 1min.
5.7 will prepare during pipe puts back into 2ml centrifuge tubes, 12,000 × g centrifugations 1min.
5.8 will prepare pipe is placed in the 1.5ml centrifuge tubes of cleaning (being provided in kit), is preparing film center plus 25-30 μ L deionized waters, are stored at room temperature 1min.12,000 × g is centrifuged 1min eluted dnas.
6th, generation sequencing
Generation sequencing is carried out using the technology based on Sanger dideoxy chain terminations, sequenator used is ABI3730xl.
7th, sequence alignment, divides influenza virus type
The sequence for obtaining will be sequenced to compare in ncbi database, unknown virus are divided to corresponding classification.
Sequence table (SEQUENCE LISTING)
<110 > Zhou Youliang
Hu Chunling Wang Haitaos Chen Feng
Wang Chaohui
<120 > HCV gene typings chips and classifying method
<160> 8
<210> 1
<211> 20
<212> DNA
<213>Artificial sequence
<400> 1
GGTTGCTCYTTYTCTATCTT
<210> 2
<211> 19
<212> DNA
<213>Artificial sequence
<400> 2
TCATCATATCCCANGCCAT
<210> 3
<211> 26
<212> DNA
<213>Artificial sequence
<400> 3
TTTTTTTTTT-ACTAGGGACGGCAAAC
<210> 4
<211> 25
<212> DNA
<213>Artificial sequence
<400> 4
TTTTTTTTTT-AGAACAACGCCTCCC
<210> 5
<2 11> 26
<212> DNA
<213>Artificial sequence
<400> 5
TTTTTTTTTT-AGAACACCAGTAAGAG
<210> 6
<211> 25
<212> DNA
<213>Artificial sequence
<400> 6
TTTTTTTTTT-AGCTAGTCTAGGGTG
<210>7
<211> 27
<212> DNA
<213>Artificial sequence
<400> 7
TTTTTTTTTT-GTCTGGTCTAGAGCACA
<210> 8
<2 11> 24
<212> DNA
<213>Artificial sequence
<400> 8
TTTTTTTTTT-GGCTCTTACCTACG

Claims (2)

1. a kind of method that parting is carried out using gene infected by influenza, it is characterised in that comprise the following steps:
Step S1, viral RNA are extracted;
Step S2, by viral RNA reverse transcription be cDNA;
Step S3, entered using specific primer performing PCR amplification;
Step S4, recovery pcr amplification product;
Step S5, the recovery product is sequenced;
Step S6, known array in sequencing result and public database is compared, unknown virus are divided to corresponding class Not.
2. a kind of method that parting is carried out using gene infected by influenza as claimed in claim 1, it is characterised in that the spy The nucleotide sequence of specific primer such as SEQ ID NO:1 to SEQ ID NO:Shown in 8.
CN201611226906.0A 2016-12-27 2016-12-27 A kind of method that parting is carried out using gene infected by influenza Pending CN106854682A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611226906.0A CN106854682A (en) 2016-12-27 2016-12-27 A kind of method that parting is carried out using gene infected by influenza

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611226906.0A CN106854682A (en) 2016-12-27 2016-12-27 A kind of method that parting is carried out using gene infected by influenza

Publications (1)

Publication Number Publication Date
CN106854682A true CN106854682A (en) 2017-06-16

Family

ID=59125983

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611226906.0A Pending CN106854682A (en) 2016-12-27 2016-12-27 A kind of method that parting is carried out using gene infected by influenza

Country Status (1)

Country Link
CN (1) CN106854682A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102286644A (en) * 2011-08-26 2011-12-21 李艳 Kit for genotyping hepatitis C virus (HCV)
CN102337351A (en) * 2010-07-16 2012-02-01 中山大学达安基因股份有限公司 Typing detection kit for influenza virus
CN104498622A (en) * 2014-11-24 2015-04-08 湖北新纵科病毒疾病工程技术有限公司 Primers, probes, and method used for influenza virus typing
CN104611423A (en) * 2009-11-16 2015-05-13 基因特力株式会社 Genotyping method
KR20150134004A (en) * 2014-05-21 2015-12-01 대한민국(농림축산식품부 농림축산검역본부장) Nucleic acid test based avian influenza virus detection kit with improved detection accuracy

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104611423A (en) * 2009-11-16 2015-05-13 基因特力株式会社 Genotyping method
CN102337351A (en) * 2010-07-16 2012-02-01 中山大学达安基因股份有限公司 Typing detection kit for influenza virus
CN102286644A (en) * 2011-08-26 2011-12-21 李艳 Kit for genotyping hepatitis C virus (HCV)
KR20150134004A (en) * 2014-05-21 2015-12-01 대한민국(농림축산식품부 농림축산검역본부장) Nucleic acid test based avian influenza virus detection kit with improved detection accuracy
CN104498622A (en) * 2014-11-24 2015-04-08 湖北新纵科病毒疾病工程技术有限公司 Primers, probes, and method used for influenza virus typing

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
E. STARICK ET AL.,: ""Type- and Subtype-Specific RT-PCR Assays for Avian Influenza A Viruses (AIV)"", 《J.VET.MED.B》 *
梁新乐: "《现代微生物学实验指导》", 31 March 2014, 浙江工商大学出版社 *
王斗: ""常见流感病毒分型基因芯片检测方法的建立和应用"", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》 *
薛文仲等: ""流感病毒的检测和分型技术研究进展"", 《生物技术通讯》 *

Similar Documents

Publication Publication Date Title
Liu et al. Molecular characterization of a bovine enteric calicivirus: relationship to the Norwalk-like viruses
Nasri et al. Typing of human enterovirus by partial sequencing of VP2
Zell et al. Detection of porcine enteroviruses by nRT–PCR: differentiation of CPE groups I–III with specific primer sets
Naito et al. Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease
Doan et al. Molecular genotyping of duck hepatitis A viruses (DHAV) in Vietnam
CN110184393A (en) A kind of primer sets, purposes, kit and its detection method detecting African swine fever virus
CN109517927A (en) A kind of A type, influenza B virus rapid typing detection reagent box and its application
Ashmi et al. Molecular characterization of canine distemper virus from Tamil Nadu, India
Mojsiejczuk et al. Molecular epidemiology of hepatitis B virus in Misiones, Argentina
CN106939355A (en) A kind of screening of influenza virus attenuated live vaccines strain and authentication method
Gagliardi et al. Human bocavirus respiratory infections in children
CN116479189A (en) Whole-gene capturing method, primer combination and kit for syncytial virus subtype B
CN106854682A (en) A kind of method that parting is carried out using gene infected by influenza
Venegas et al. Prevalence of hepatitis B virus genotypes in chronic carriers in Santiago, Chile
CN103614345A (en) Influenza virus vaccine strain
CN103614495B (en) Joint detection kit for influenza viruses A and B and application thereof
Atmar et al. Typing and subtyping clinical isolates of influenza virus using reverse transcription-polymerase chain reaction
Yan et al. CRF01_AE/B/C, a novel drug-resistant HIV-1 recombinant in men who have sex with men in Beijing, China
Mahmood et al. Analysis of complete and partial genome sequences of hepatitis B virus and determination of its genotypes and sub-genotypes from Pakistan
Hijikata et al. Genotyping of hepatitis E virus from Vietnam
Zhen et al. Emergence of a novel pegivirus species in southwest China showing a high rate of coinfection with parvovirus and circovirus in geese
CN101857872A (en) Replacement method of influenza A Virus antigenic determinant
Soltanialvar et al. Genetic analysis of polymerase complex (PA, PB1 and PB2) genes of H9N2 avian influenza viruses from Iran (1999 to 2009)
Kareem et al. Hepatitis C Virus Genotyping In Sulaimani Governorate
WO2019129254A1 (en) New use of influenza virus antibody

Legal Events

Date Code Title Description
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170616